Physician profile
Michael Y Wang
NPI 1053347906
$2,198,068.70
in general payments reported to CMS, 2019-2025
45 companies · $327K in 2025
The $327K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $514K · 2020: $398K · 2021: $307K · 2022: $202K · 2023: $210K · 2024: $240K · 2025: $327K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $586K · Travel and Lodging: $69K · Royalty Or License: $52K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $26K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,250 · Entertainment: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $586,261.67 |
| Travel and Lodging | $69,116.15 |
| Royalty Or License | $51,608.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,000.00 |
| Food and Beverage | $25,596.66 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,250.00 |
| Entertainment | $490.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $690,191.47 | 2019-2025 | |
| Medical Device Business Services, INC. | $372,748.12 | 2019-2025 | Pds, Dermabond, Monocryl |
| Medtronic, INC. | $292,815.77 | 2021-2025 | Endoskeleton Tl Nanolock Surface Technology, Cd Horizon Spinal System, Catalyft Pl Expandable Interbody System |
| Stryker Corporation | $260,601.27 | 2019-2025 | Mako, Everest Spinal System, Sahara Stabilization System |
| Spineology INC. | $172,483.83 | 2019-2025 | Optimesh Expandable Interbody Fusion System |
| Globus Medical, INC. | $101,796.92 | 2019-2025 | Reline, Xlif, Pulse |
| Ethicon INC. | $74,825.00 | 2020-2024 | Surgiflo Hemostatic Matrix, Dermabond, Stratafix |
| Pacira Pharmaceuticals Incorporated | $63,797.33 | 2021-2025 | Exparel, Iovera, Zilretta |
| Medtronic USA, INC. | $38,946.69 | 2019-2020 | |
| Ethicon US, LLC | $34,516.50 | 2021-2025 | Stratafix, Dermabond, Monocryl |
| Nuvasive, INC. | $26,360.01 | 2021-2023 | Reline, Xlif, Pcm |
| Surgalign Spine Technologies, INC. | $16,612.89 | 2021-2022 | |
| Vb Spine LLC | $16,231.36 | 2025 | Yukon Oct Spinal System, Everest Spinal System, Escalate |
| Augmedics INC. | $11,064.77 | 2020-2025 | Xvision |
| Kuros Biosciences USA, INC | $9,202.87 | 2023-2025 | Magnetos |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $5,273.57 | 2019-2024 | Expedium, Teligen, Symphony |
| Joimax, INC. | $3,459.50 | 2019-2025 | |
| Alphatec Spine, INC | $2,596.42 | 2024-2025 | Other - Miscellaneous, Invictus Mis, Lif |
| Mirus, LLC | $695.80 | 2023 | Io Expandable Lumbar Interbody, Europa Pedicle Screw System, 3dr Lumbar Interbody |
| Integrity Implants INC. | $630.94 | 2020 | |
| Synthes Gmbh | $500.00 | 2021 | |
| 4web, INC. | $430.13 | 2019-2024 | Spine Truss System |
| Carlsmed, INC. | $357.75 | 2022-2023 | Aprevo |
| Curiteva, INC. | $218.31 | 2023 | |
| Biocomposites INC | $213.41 | 2021-2024 | |
| Implanet America, INC. | $188.61 | 2024 | |
| Si-Bone, INC. | $166.68 | 2023 | |
| Intrinsic Therapeutics | $155.49 | 2023 | Barricaid Acd (Annular Closure Device) |
| Trackx Technology, INC. | $144.05 | 2022 | |
| Beigene USA, INC. | $106.10 | 2022-2025 | Brukinsa |
| Elevation Spine, INC. | $104.47 | 2025 | |
| Integrity Implants INC. Dba Accelus | $82.46 | 2024 | |
| Baxter Healthcare | $79.25 | 2019 | |
| Heron Therapeutics, INC. | $77.51 | 2021 | |
| Prosidyan, INC | $76.80 | 2021 | |
| Biedermann Motech, INC. | $60.70 | 2019 | |
| Osteocentric Technologies, INC. | $60.26 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Innovasis INC | $46.05 | 2022 | |
| Seaspine Orthopedics Corporation | $42.57 | 2022 | |
| Amarin Pharma, INC. | $33.36 | 2019 | |
| Zimmer Biomet Holdings, INC. | $23.74 | 2019 | |
| Therapeuticsmd, INC. | $21.98 | 2019 | |
| Astellas Pharma US INC | $19.46 | 2019 | |
| Pfizer INC. | $8.53 | 2019-2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$87,560.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$454,032.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.